Towards Healthcare
Clinical Trial Imaging Market to Drive USD 5.58 Bn by 2034

Clinical Trial Imaging Market Growth Shaped by Oncology and Neurology

Market insights predict the global clinical trial imaging industry will increase from USD 2.41 billion in 2024 to USD 5.58 billion by 2034, achieving a CAGR of 8.8%. The market is growing due to the increasing adoption of advanced imaging technologies for accurate disease diagnosis and treatment monitoring. Rising demand for efficient, non-invasive, and real-time assessment in drug development further drives market expansion.

Content

  • Last Updated: 16 September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The clinical trial imaging market is valued at USD 2.62 billion in 2025 and is on track to reach USD 5.58 billion by 2034, witnessing a steady CAGR of 8.8% during the forecast span.

North America is currently leading the clinical trial imaging market share 42% due to its mature clinical research ecosystem and high concentration of specialized imaging centers.

The clinical trial imaging market includes five segments by service type, by imaging modality, by therapeutic area, by end user, and by region.

Key trends include the growth due to the increasing adoption of advanced imaging technologies for accurate disease diagnosis and treatment monitoring.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions